The mammalian testis-determining gene Sry and the related Sox genes define a family of transcriptional regulators widely expressed during embryogenesis. Tightly controlled temporal profiles of expression are a feature of the Sox gene family and may be required for initiation of a cascade of gene expression, yet the molecular mechanisms that control Sox gene expression are unknown. We now show that human SOX4 is expressed in the normal breast and in breast cancer cells. In these cells SOX4 is a progesterone-regulated gene, the expression of which is increased by progestins, leading to a marked increase in SOX-mediated transcriptional activity. Treatment of T-47D breast cancer cells with the synthetic progestin ORG 2058 directly increased SOX4 transcription, resulting in a 4-fold increase in SOX4 mRNA levels within 4 h of treatment. No effect of ORG 2058 was noted on other SOX genes measured, nor were other hormone-regulated HMG box proteins detected in this system, suggesting that the observed ability of progestin to increase SOX mRNA expression was confined to SOX4. The increase in SOX4 transcription was reflected in increased SOX4 protein expression, as progestin treatment of T-47D cells transfected with a SOX-responsive reporter resulted in a marked increase in reporter gene expression. Progesterone is essential for normal development and differentiation of the female reproductive system, plays an essential role in regulating growth and differentiation of the mammary gland and is required for opposing the proliferative effects of estrogen in specific cell types. The detection of SOX4 expression in the normal and malignant breast and the demonstration that SOX4 expression is under progesterone control suggests that changes in SOX4 gene expression may play a role in commitment to the differentiated phenotype in the normal and malignant mammary gland.

This article has been cited by other articles:

				M. M White, I. Sheffer, J. Teeter, and E. M. Apostolakis Hypothalamic progesterone receptor-A mediates gonadotropin surges, self priming and receptivity in estrogen-primed female mice J. Mol. Endocrinol., January 1, 2007; 38(1): 35 - 50. [Abstract] [Full Text] [PDF]

				P. Liu, S. Ramachandran, M. Ali Seyed, C. D. Scharer, N. Laycock, W. B. Dalton, H. Williams, S. Karanam, M. W. Datta, D. L. Jaye, et al. Sex-determining region y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res., April 15, 2006; 66(8): 4011 - 4019. [Abstract] [Full Text] [PDF]

				M. Aaboe, K. Birkenkamp-Demtroder, C. Wiuf, F. B. Sorensen, T. Thykjaer, G. Sauter, K. M.-E. Jensen, L. Dyrskjot, and T. Orntoft SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization. Cancer Res., April 1, 2006; 66(7): 3434 - 3442. [Abstract] [Full Text] [PDF]

				J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735. [Abstract] [Full Text] [PDF]

				K. E. Bethin, Y. Nagai, R. Sladek, M. Asada, Y. Sadovsky, T. J. Hudson, and L. J. Muglia Microarray Analysis of Uterine Gene Expression in Mouse and Human Pregnancy Mol. Endocrinol., August 1, 2003; 17(8): 1454 - 1469. [Abstract] [Full Text] [PDF]

				H. F. Frierson Jr, A. K. El-Naggar, J. B. Welsh, L. M. Sapinoso, A. I. Su, J. Cheng, T. Saku, C. A. Moskaluk, and G. M. Hampton Large Scale Molecular Analysis Identifies Genes with Altered Expression in Salivary Adenoid Cystic Carcinoma Am. J. Pathol., October 1, 2002; 161(4): 1315 - 1323. [Abstract] [Full Text] [PDF]

				E. M. McGowan and C. L. Clarke Effect of Overexpression of Progesterone Receptor A on Endogenous Progestin-Sensitive Endpoints in Breast Cancer Cells Mol. Endocrinol., October 1, 1999; 13(10): 1657 - 1671. [Abstract] [Full Text]